Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Benzodiazepines effective against alcohol withdrawal seizures

31.08.2005


Tranquilizers work better than placebos at treating the symptoms of alcohol withdrawal syndrome but they may not work better than other drugs, according to a new review of recent studies.



The class of depressant drugs known as benzodiazepines are especially effective at treating seizure in withdrawal patients, say Dr. Christos Ntais of the University of Ioannina School of Medicine in Greece and colleagues. People given benzodiazepines were 84 percent less likely to have withdrawal-related seizures compared to those given placebos.

“This might suggest that their [benzodiazepines’] current status as first-line treatment for alcohol withdrawal syndrome is justified,” Ntais and colleagues say.


However, the researchers found no evidence that benzodiazepines are any better than other drugs used for treating alcohol withdrawal syndrome or that there are any differences between types of benzodiazepines for withdrawal treatment.

“There was no conclusive evidence or even hints for superiority of specific drugs, but modest differences could have been missed due to limited data,” Ntais says.

Among the commonly known benzodiazepines are Halcion, Versed, Librium, Xanax and Valium.

In a second review, Dr. Anastasia Polycarpou, also of the University of Ioannina School of Medicine, and colleagues found some evidence that anticonvulsant drugs such as carbamazepine (Epitol or Tegretol, for example) are more effective than placebo at treating alcohol withdrawal, but the difference was not statistically significant.

The reviews appear in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

Alcoholics can go through withdrawal when they stop or cut back on their drinking. Symptoms of withdrawal can include everything from insomnia, sweating and rapid heart beat to nausea, seizures and hallucinations. The most severe form of withdrawal syndrome is called delirium tremens.

Alcohol addiction affects certain neurotransmitter circuits in the brain, and the symptoms of alcohol withdrawal reflect the brain’s attempt to readjust those circuits. Benzodiazepines act on one particular type of circuit called GABA pathways.

Ntais and colleagues examined 57 studies of benzodiazepine treatment for 4,051 people. Polycarpou and colleagues analyzed 48 studies of anticonvulsant treatment for 3,610 people. Although the number of studies is relatively high for systematic reviews, the studies had a large variety of outcomes and measurements that made it difficult to combine and analyze the data as a whole, according to both review teams.

Although not all of the studies reported side effects from the drugs, deaths and serious complications from the treatments appear to be rare, the reviewers say.

“The extremely small mortality rate in all these studies is reassuring, but data on other harms-related outcomes are sparse and fragmented,” Ntais says.

Sarah Book, a professor at the Medical University of South Carolina who has studied the effects of both benzodiazepines and anticonvulsants for alcohol withdrawal, says there may be other reasons to be cautious about benzodiazepine treatment.

“In general, benzodiazepines have the potential to increase the risk of [alcoholic] relapse,” Book says.

Book also says “the combination of alcohol and benzodiazepines can be deadly,” a problem that does not occur with anticonvulsants, she adds.

According to Book, the majority of benzodiazepine prescriptions for withdrawal are made on an outpatient basis, with little opportunity to monitor a patient’s continued drinking.

The Cochrane reviews were supported by the European Community, Directorate of Public Health.

Ntais C, Pakos E, Kyzas P, Ioannidis JPA. Benzodiazepines for alcohol withdrawal. The Cochrane Database of Systematic Reviews 2005, Issue 3.

Polycarpou A, Papanikolaou P, Ioannidis JPA,Contopoulos-Ioannidis DG. Anticonvulsants for alcohol withdrawal. The Cochrane Database of Systematic Reviews 2005, Issue 3.

The Cochrane Collaboration is an international nonprofit, independent organization that produces and disseminates systematic reviews of health care interventions and promotes the search for evidence in the form of clinical trials and other studies of interventions.

Christos Ntais | EurekAlert!
Further information:
http://www.cochrane.org
http://www.hbns.org

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>